Trial Profile
Clinical trial aimed at new therapeutic approch against HAM patients by pentosan polysulphate
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Oct 2015
Price :
$35
*
At a glance
- Drugs Pentosan polysulfate (Primary)
- Indications HTLV-I infections; Spinal cord disorders
- Focus Adverse reactions; Therapeutic Use
- 30 May 2012 New trial record